Vis enkel innførsel

dc.contributor.authorHenjum, Sigrun
dc.contributor.authorFrøyland, Livar
dc.contributor.authorHaugen, Margaretha
dc.contributor.authorHolvik, Kristin
dc.contributor.authorLøvik, Martinus
dc.contributor.authorSkålhegg, Bjørn Steen
dc.contributor.authorStea, Tonje Holte
dc.contributor.authorStrand, Tor A
dc.contributor.authorIversen, Per Ole
dc.date.accessioned2017-11-13T09:47:22Z
dc.date.available2017-11-13T09:47:22Z
dc.date.created2017-10-13T13:16:27Z
dc.date.issued2017
dc.identifier.isbn978-82-8259-268-0
dc.identifier.urihttp://hdl.handle.net/11250/2465725
dc.description.abstractAt the request of the Norwegian Food Safety Authority, the Norwegian Scientific Committee for Food Safety (VKM) has characterised the risk of specified doses of L-aspartic acid in food supplements. VKM concludes that: In adults (≥18 years), adolescents (14 to < 18 years) and children (10 to < 14 years), the specified doses 3000, 3500, 4000, 4500, 5000 and 5700 mg/day L-aspartic acid in food supplements may represent a risk of adverse health effects.nb_NO
dc.language.isoengnb_NO
dc.publisherNorwegian Scientific Committee for Food Safety (VKM)nb_NO
dc.relation.ispartofVKM Report
dc.relation.ispartofseriesVKM Report;
dc.relation.urihttps://vkm.no/risikovurderinger/allevurderinger/andrestoffer/laspartatikosttilskudd.4.761cd04215dabef8a9e830a4.html
dc.titleRisk assessment of "other substances" – L-aspartic acid. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safetynb_NO
dc.typeResearch reportnb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber32nb_NO
dc.source.issue2017:11nb_NO
dc.identifier.cristin1504456
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextoriginal


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel